Research and Markets: Seasonal Allergic Rhinitis - Pipeline Review, H2 2012 Report Out Now

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qxlnms/seasonal_allergic) has announced the addition of Global Markets Direct's new report "Seasonal Allergic Rhinitis - Pipeline Review, H2 2012" to their offering.

“Seasonal Allergic Rhinitis - Pipeline Review, H2 2012”

Global Markets Direct's, 'Seasonal Allergic Rhinitis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Seasonal Allergic Rhinitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Seasonal Allergic Rhinitis. Seasonal Allergic Rhinitis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Seasonal Allergic Rhinitis.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Seasonal Allergic Rhinitis pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

- Johnson & Johnson

- Bausch & Lomb Incorporated

- Shionogi & Co., Ltd.

- GlaxoSmithKline plc

- Merck & Co., Inc.

- Dainippon Sumitomo Pharma Co., Ltd.

- Novartis AG

- ALK-Abello A/S

- Mitsubishi Tanabe Pharma Corporation

- Teva Pharmaceutical Industries Limited

- Zeria Pharmaceutical Co Ltd

- Sun Pharmaceutical Industries Limited

- Capnia, Inc.

- VentiRx Pharmaceuticals, Inc.

- Adamis Pharmaceuticals Corporation

- Indigene Pharmaceuticals, Inc.

For more information visit http://www.researchandmarkets.com/research/qxlnms/seasonal_allergic

Source: Global Markets Direct